St. Joe's diabetes research gets $2.5 million injection
|
Danny Baylis, LondonTopic.ca |
|
|
11/08/2009 |
New light for those living with diabetes is planned for London in a $2.5
million investment by The Lawson Foundation.
Beginning in 2012, a prestigious new research position will be established
at the Lawson Health Research Institute, the research arm of St. Joseph's
Health Care, London.
Known as The Helen and Frances Lawson Chair in Diabetes Research, the new
Chair will create and lead a diabetes research group with a goal to make
significant advances in the understanding, prevention, treatment and
reversal of both type 1 and 2 diabetes. Additionally the chair holder will
act as a catalyst to create an integrated program of diabetes research and
care at St. Joseph's Health Care, London.
"We are very grateful to The Lawson Foundation, for their vision, commitment
and proactive approach to research investment," says Dr. David Hill,
director, Lawson Health Research Institute.
"The creation of the research chair ensures that a senior scientist will
always be leading a group at St Joseph's Health Care, London focusing on the
prevention or better control of diabetes, which now affects 1 in 10
Canadians," Hill said.
"Without innovative solutions the costs of treating complications of
diabetes such as heart attack, stroke and blindness will cripple our health
system. Continuing sustained research is critical - otherwise, the
demographics and the impact of diabetes will overwhelm us and we won't be
able to deal with the consequences," he said.
The Health Council of Canada 2007 Report forecasts that if trends continue
with Canada's population inactive, overweight and aging, and with an
estimated 60,000 new cases of diabetes diagnosed each year, the number of
Canadians diagnosed with diabetes is expected to nearly double by 2016 far
outpacing population growth.
By 2016, The Public Health Agency of Canada has predicted that with the
aging of Canada's population, total direct health care costs associated with
diabetes could increase to over $8 billion annually.
According to Michelle Campbell, president and CEO of St. Joseph's Health
Care Foundation, "The creation of this Chair is further demonstration of the
(Lawson Foundation) commitment to supporting diabetes care across the
country."
The gift augments an existing endowment at St. Joseph's begun in the 1970's
with the Lawson Foundation's installment of a senior diabetes research
professorship to better understand the disease and its solutions. The new
Chair position will bring the total endowment value to $3.5 million and
ensure the foundation's goal for sustainability of diabetes research in
Canada.
To date, the Foundation has awarded 25 grants totaling $3,000,000 to
projects in type 1 and type 2 diabetes.
|